Matuszyk et al., 2021)
Thus, G6PD is considered a major enzyme for the cellular defense against oxidative stress (Pandolfi et al., 1995) and its activity is strongly modulated in response to oxidants (Kletzien et al., 1994)
pharmacological treatment DBS is indicated in patients with severe motor fluctuations and Levodopa-induced dyskinesia
Life sciences, 1996, 58 20: 1777-1784
7 Systemic metabolic disorders that contribute to Alzheimer's disease 7.1 Diabetes, insulin resistance and metabolic syndrome The complex interplay of diabetes, dyslipidemia, obesity, and hypertension in clinical settings makes it challenging to pinpoint their individual roles in pathology
1 This article will give you an in-depth exploration of semaglutide and its side effects